Riley S C, Dupont E, Walton J C, Luu-The V, Labrie F, Pelletier G, Challis J R
Lawson Research Institute, St. Joseph's Health Centre, London, Ontario, Canada.
J Clin Endocrinol Metab. 1992 Sep;75(3):956-61. doi: 10.1210/jcem.75.3.1381375.
The regulation of steroid production by the placenta and fetal membranes is important for both the maintenance of pregnancy and the timing of parturition. 3 beta-Hydroxy-5-ene-steroid dehydrogenase/delta 5----delta 4-isomerase (3 beta HSD) catalyzes an obligatory step in the biosynthesis of steroid hormones. We have determined the localization of 3 beta HSD in the human placenta, fetal membranes, and umbilical cord throughout gestation by immunohistochemical analysis, using a polyclonal antibody raised in rabbits against a purified preparation of human placental 3 beta HSD. In placenta, immunoreactive (IR-) 3 beta HSD was localized in the syncytiotrophoblast and intermediate trophoblast cells at both villous and extravillous sites, but not in cytotrophoblast cells from 6 weeks gestation to term. At 6-7 weeks gestation, IR-3 beta HSD was distributed in the cytoplasm of syncytiotrophoblast in about half of placental villi. By 12-14 weeks, the syncytiotrophoblast of all placental villi stained positively for 3 beta HSD. In the fetal membranes, strong IR-3 beta HSD staining was found in the trophoblast and reticular layers of chorion and in invasive trophoblast cells in decidua, and weakly in decidual stromal cells and amniotic epithelium. No IR-3 beta HSD was found in amnion on the placental plate, but in the umbilical cord, IR-3 beta HSD was present in the amniotic epithelium and also in fibroblast cells in Warton's jelly. These observations demonstrate that the localization of 3 beta HSD immunoreactivity and, therefore, the presumed sites of delta 5- to delta 4-steroid interconversion throughout gestation are principally the syncytiotrophoblast and intermediate trophoblast cells in placenta and the trophoblast cells in chorion and decidua in fetal membranes.
胎盘和胎膜对甾体激素生成的调节对于维持妊娠和分娩时机都很重要。3β-羟基-5-烯-甾体脱氢酶/δ5→δ4异构酶(3βHSD)催化甾体激素生物合成中的一个必需步骤。我们通过免疫组织化学分析,使用针对纯化的人胎盘3βHSD制备物在兔体内产生的多克隆抗体,确定了整个妊娠期人胎盘、胎膜和脐带中3βHSD的定位。在胎盘中,免疫反应性(IR-)3βHSD定位于绒毛和绒毛外部位的合体滋养层细胞和中间滋养层细胞,但在妊娠6周直至足月的细胞滋养层细胞中未发现。在妊娠6 - 7周时,IR-3βHSD分布在约一半胎盘绒毛的合体滋养层细胞质中。到12 - 14周时,所有胎盘绒毛的合体滋养层细胞对3βHSD染色呈阳性。在胎膜中,在绒毛膜的滋养层和网状层以及蜕膜中的侵袭性滋养层细胞中发现强IR-3βHSD染色,而在蜕膜基质细胞和羊膜上皮中染色较弱。在胎盘板上的羊膜中未发现IR-3βHSD,但在脐带中,IR-3βHSD存在于羊膜上皮以及华通胶中的成纤维细胞中。这些观察结果表明,3βHSD免疫反应性的定位,以及因此整个妊娠期推测的δ5至δ4甾体转化位点主要是胎盘中的合体滋养层细胞和中间滋养层细胞以及胎膜中绒毛膜和蜕膜中的滋养层细胞。